业务
制药工业
计算机科学
计量经济学
营销
知识管理
数学
医学
药理学
作者
Kaspar Rufibach,Marcel Wolbers,Jenny Devenport,Godwin Yung,Chris Harbron,Alun Bedding,Zhiyue Huang,Ray Lin,Herbert Pang,Daniel Sabanés Bové,Jianmei Wang
标识
DOI:10.1080/19466315.2024.2327291
摘要
Innovation, defined as the successful implementation at scale of a new invention, is key for continued success of the drug development enterprise. In this article we focus on statistical innovation in the pharmaceutical industry. We discuss both components, invention and implementation at scale, typically called commercialization, of innovation for statistical methods. These concepts are illustrated using three examples that we successfully implemented in our company. We summarize factors that foster or hinder invention and commercialization. A discussion of the mindset we consider supportive of innovation and how organizational leaders and professional organizations can generate an environment that fosters innovation concludes the article.
科研通智能强力驱动
Strongly Powered by AbleSci AI